DK1053012T3 - Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner - Google Patents
Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektionerInfo
- Publication number
- DK1053012T3 DK1053012T3 DK99906749T DK99906749T DK1053012T3 DK 1053012 T3 DK1053012 T3 DK 1053012T3 DK 99906749 T DK99906749 T DK 99906749T DK 99906749 T DK99906749 T DK 99906749T DK 1053012 T3 DK1053012 T3 DK 1053012T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- pharmaceutical compositions
- hiv infections
- inhibitor compounds
- peg
- Prior art date
Links
- 208000031886 HIV Infections Diseases 0.000 title 1
- 108010001564 pegaspargase Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 108010078851 HIV Reverse Transcriptase Proteins 0.000 abstract 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 abstract 1
- 229940123934 Reductase inhibitor Drugs 0.000 abstract 1
- 102000000505 Ribonucleotide Reductases Human genes 0.000 abstract 1
- 108010041388 Ribonucleotide Reductases Proteins 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 1
- 239000003419 rna directed dna polymerase inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7406698P | 1998-02-09 | 1998-02-09 | |
| PCT/US1999/002480 WO1999039732A1 (en) | 1998-02-09 | 1999-02-09 | Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1053012T3 true DK1053012T3 (da) | 2003-11-17 |
Family
ID=22117505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99906749T DK1053012T3 (da) | 1998-02-09 | 1999-02-09 | Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1053012B1 (de) |
| JP (1) | JP2002502826A (de) |
| AT (1) | ATE245444T1 (de) |
| AU (1) | AU752434B2 (de) |
| CA (1) | CA2319356A1 (de) |
| DE (1) | DE69909747T2 (de) |
| DK (1) | DK1053012T3 (de) |
| ES (1) | ES2203072T3 (de) |
| WO (1) | WO1999039732A1 (de) |
| ZA (1) | ZA991029B (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4030200A (en) * | 1999-04-02 | 2000-10-23 | Children's Hospital Of Los Angeles | Use of asparaginase and glutaminase to treat autoimmune disease and graft versushost disease |
| CA2346063A1 (en) * | 1999-08-06 | 2001-02-15 | Vassilios L. Avramis | Composition and methods for treatment of hiv infection |
| CA2404737C (en) | 2000-04-03 | 2010-06-29 | Santen Pharmaceutical Co., Ltd. | Drug delivering substance containing polyalkylene glycol and phospholipid covalently bonded to drug |
| US6911460B2 (en) | 2001-04-20 | 2005-06-28 | Vion Pharmaceuticals, Inc. | Antiviral agents and methods of treating viral infections |
| ES2381998T3 (es) | 2002-11-26 | 2012-06-04 | The University Of Chicago | Prevención y tratamiento de trastornos eipiteliales mediados por microbios |
| US20080299105A1 (en) * | 2004-09-13 | 2008-12-04 | Runtao He | Inhibition of Feline Calicivirus |
| CN101002945B (zh) | 2006-01-20 | 2012-09-05 | 清华大学 | 一种用于肿瘤治疗的新型复合物 |
| CN100475270C (zh) | 2006-01-20 | 2009-04-08 | 清华大学 | 一种治疗肿瘤的药物及其应用 |
| GB0608876D0 (en) * | 2006-05-05 | 2006-06-14 | Medivir Ab | Combination therapy |
| CN101219219B (zh) | 2007-01-10 | 2013-02-13 | 北京普罗吉生物科技发展有限公司 | 包含血管抑素或其片段的复合物、其制备方法及应用 |
| WO2015033344A1 (en) * | 2013-09-05 | 2015-03-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs) |
| JP6846574B2 (ja) * | 2017-11-29 | 2021-03-24 | 大鵬薬品工業株式会社 | スルホンアミド化合物およびその使用 |
| US20210299233A1 (en) | 2018-07-12 | 2021-09-30 | The Children's Medical Center Corporation | Method for treating cancer |
| CN115671102A (zh) * | 2022-11-17 | 2023-02-03 | 中国科学院大学 | 3-ap在制备抑制痘病毒的药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2600256B1 (fr) * | 1986-06-19 | 1988-09-16 | Inst Nat Sante Rech Med | Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus |
| WO1998056410A1 (en) * | 1997-06-09 | 1998-12-17 | Childrens Hospital Los Angeles | Utilization of wolinella succinogenes asparaginase to treat diseases associated with asparagine dependence |
-
1999
- 1999-02-09 CA CA002319356A patent/CA2319356A1/en not_active Abandoned
- 1999-02-09 WO PCT/US1999/002480 patent/WO1999039732A1/en active IP Right Grant
- 1999-02-09 EP EP99906749A patent/EP1053012B1/de not_active Expired - Lifetime
- 1999-02-09 JP JP2000530229A patent/JP2002502826A/ja active Pending
- 1999-02-09 AU AU26584/99A patent/AU752434B2/en not_active Ceased
- 1999-02-09 ES ES99906749T patent/ES2203072T3/es not_active Expired - Lifetime
- 1999-02-09 DE DE69909747T patent/DE69909747T2/de not_active Expired - Fee Related
- 1999-02-09 DK DK99906749T patent/DK1053012T3/da active
- 1999-02-09 AT AT99906749T patent/ATE245444T1/de not_active IP Right Cessation
- 1999-02-09 ZA ZA9901029A patent/ZA991029B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA991029B (en) | 1999-09-30 |
| ES2203072T3 (es) | 2004-04-01 |
| AU752434B2 (en) | 2002-09-19 |
| WO1999039732A1 (en) | 1999-08-12 |
| CA2319356A1 (en) | 1999-08-12 |
| DE69909747T2 (de) | 2004-04-15 |
| ATE245444T1 (de) | 2003-08-15 |
| DE69909747D1 (de) | 2003-08-28 |
| EP1053012A1 (de) | 2000-11-22 |
| AU2658499A (en) | 1999-08-23 |
| EP1053012B1 (de) | 2003-07-23 |
| JP2002502826A (ja) | 2002-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE377011T1 (de) | Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1- piperazinpentanamide als hiv-proteasehemmer | |
| DK1053012T3 (da) | Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner | |
| EA200001030A1 (ru) | Получение капсул и таблеток быстрорастворяющегося эфавиренза с использованием супердезинтеграторов | |
| BR0013771A (pt) | Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica | |
| ATE252081T1 (de) | Neue hiv-protease-inhibitoren | |
| EA200200778A1 (ru) | СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ИНФЕКЦИИ ГЕПАТИТА С В ОРГАНИЗМЕ ХОЗЯИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ПРОТИВ ФЛАВИВИРУСА, СОЕДИНЕНИЕ ФОРМУЛЫ Ib - АКТИВНЫЙ АГЕНТ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ИНФЕКЦИИ ГЕПАТИТА С ИЛИ ФЛАВИВИРУСА (ВАРИАНТЫ) | |
| EA200701869A1 (ru) | Пептидомиметические ингибиторы протеазы | |
| GEP20104960B (en) | USE OF [D-MeALa]3-[EtVal]4-CYCLOSPORIN FOR THE TREATMENT OF HEPATITIS C INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID [D-MeAla]3-[EtVal]4-CYCLOSPORIN | |
| SG52628A1 (en) | Substituted cyclic carbonyls and derivatives thereof useful as retrobiral protease inhibitors | |
| ATE327246T1 (de) | Hepatitis c tripeptid inhibitoren | |
| EA200400585A1 (ru) | N-замещённые гидроксипиримидинон-карбоксамидные ингибиторы вич интегразы | |
| ATE238998T1 (de) | Substituierte benzimidazole als nicht-nucleoside reverse transcriptase inhibitore | |
| BR9607625A (pt) | Inibidores de protease retroviral sulfonamida hidroxietilamino de aminoácido heterociclocarbonila | |
| DE69430385D1 (de) | Hiv-proteaseinhibitoren | |
| WO2006044968A3 (en) | Combination therapy for treating viral infections | |
| WO2001010454A3 (en) | Pharmaceutical composition comprising peg-asparaginase for the treatment of hiv infection | |
| EE9700165A (et) | Ühendite kombinatsioon, meetod ja farmatseutiline kompositsioon HIV proteaasi ja HIV pöördtranskriptaasi inhibeerimiseks ning HIV infektsiooni vältimiseks või raviks, või AIDS-i või ARC raviks | |
| HK1045456A1 (en) | Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection | |
| NO965591L (no) | Kombinasjonsbehandling av HIV-infeksjon | |
| UA41338C2 (uk) | Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл) | |
| EA200000513A1 (ru) | Комбинированная терапия для лечения спид | |
| NO20024522D0 (no) | Sammensetninger med anti-hiv-aktivitet | |
| DE69529678D1 (de) | Kombinationen von hiv-protease inhibitoren | |
| UA31078A (uk) | Інгібітор вірусу імунодефіциту людини ( даримід ) | |
| TR199902508T2 (xx) | HIV proteaz inhibit�rleri. |